Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.440
Sell
RSI(14)
30.910
Neutral
STOCH(KDJ)(9,3,3)
12.910
Oversold
ATR(14)
0.738
Low Volatility
CCI(14)
-104.810
Sell
Williams %R
81.702
Oversold
TRIX(12,20)
-0.899
Sell
StochRSI(14)
100.000
Buy
Cellebrite DI Ltd
CLBT14.170USD
+0.580+4.27%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
3.46BMarket Cap
36.66P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Cellebrite DI Ltd
Currency: USD Updated: 2026-02-05Key Insights
Cellebrite DI Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 63 out of 482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 24.67.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cellebrite DI Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Cellebrite DI Ltd Highlights
StrengthsRisks
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 48.24% year-on-year.
Overvalued
The company’s latest PE is 35.16, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 134.83M shares, increasing 0.05% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 133.52K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.69.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
24.667
Target Price
+65.55%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-05The current financial score of Cellebrite DI Ltd is 8.71, ranking 49 out of 482 in the Software & IT Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 126.03M, representing a year-over-year increase of 17.94%, while its net profit experienced a year-over-year increase of 109.75%.
Score
Financials
9.72
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.72
Operational Efficiency
8.73
Growth Potential
8.95
Shareholder Returns
7.43
Cellebrite DI Ltd's Company Valuation
Currency: USD Updated: 2026-02-05The current valuation score of Cellebrite DI Ltd is 7.28, ranking 278 out of 482 in the Software & IT Services industry. Its current P/E ratio is 35.16, which is 64.77% below the recent high of 57.93 and 196.20% above the recent low of -33.82.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 63/482
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-05The current earnings forecast score of Cellebrite DI Ltd is 8.29, ranking 66 out of 482 in the Software & IT Services industry. The average price target is 24.00, with a high of 28.00 and a low of 23.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
24.667
Target Price
+81.51%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
242
Total
9
Median
12
Average
Company name
Ratings
Analysts
Cellebrite DI Ltd
CLBT
7
Microsoft Corp
MSFT
60
Palo Alto Networks Inc
PANW
55
CrowdStrike Holdings Inc
CRWD
54
Zscaler Inc
ZS
49
ServiceNow Inc
NOW
47
1
2
3
...
49
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-05The current price momentum score of Cellebrite DI Ltd is 6.63, ranking 201 out of 482 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 17.05 and the support level at 11.83, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
14.178
Sell
MA10
15.005
Sell
MA20
16.016
Sell
MA50
17.329
Sell
MA100
17.597
Sell
MA200
16.952
Sell
Institutional Confidence
Currency: USD Updated: 2026-02-05The current institutional shareholding score of Cellebrite DI Ltd is 5.00, ranking 226 out of 482 in the Software & IT Services industry. The latest institutional shareholding proportion is 62.11%, representing a quarter-over-quarter decrease of 2.39%. The largest institutional shareholder is James Simons, holding a total of 2.90M shares, representing 1.19% of shares outstanding, with 8.91% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-02-05The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Software & IT Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Cellebrite DI Ltd is 6.24, ranking 150 out of 482 in the Software & IT Services industry. The company's beta value is 1.29. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
1.29
VaR
+4.43%
240-Day Maximum Drawdown
+34.40%
240-Day Volatility
+50.16%
Return
Best Daily Return
60 days
+20.73%
120 days
+20.73%
5 years
+20.73%
Worst Daily Return
60 days
-5.15%
120 days
-6.19%
5 years
-13.94%
Sharpe Ratio
60 days
-0.61
120 days
+0.11
5 years
+0.37
Risk Assessment
Maximum Drawdown
240 days
+34.40%
3 years
+48.00%
5 years
+67.74%
Return-to-Drawdown Ratio
240 days
-0.73
3 years
+0.98
5 years
+0.13
Skewness
240 days
+1.58
3 years
+0.84
5 years
+0.70
Volatility
Realised Volatility
240 days
+50.16%
5 years
+54.28%
Standardised True Range
240 days
+4.62%
5 years
+3.12%
Downside Risk-Adjusted Return
120 days
+21.62%
240 days
+21.62%
Maximum Daily Upside Volatility
60 days
+52.58%
Maximum Daily Downside Volatility
60 days
+42.76%
Liquidity
Average Turnover Rate
60 days
+0.75%
120 days
+0.64%
5 years
--
Turnover Deviation
20 days
+68.81%
60 days
+28.16%
120 days
+8.07%
Peer Comparison
Software & IT Services
Cellebrite DI Ltd
CLBT
7.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Visa Inc
V
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
A10 Networks Inc
ATEN
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Mastercard Inc
MA
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Progress Software Corp
PRGS
8.32 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amdocs Ltd
DOX
8.26 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
